Pharma & Biotech

Annovis Bio shares experienced a dramatic upward move following the release of encouraging clinical trial data for its Parkinson's disease...

Biotechnology firm Kezar Life Sciences is embarking on a fundamental strategic shift after encountering a significant regulatory obstacle. The U.S....

Skye Bioscience's stock is experiencing another significant downturn this week as the biotechnology firm faces a new class-action lawsuit. The...

Bioatla Inc. witnessed a dramatic surge in its share price, climbing nearly 20 percent following the release of its latest...

Investor attention turned to Aclaris Therapeutics this week following the company's presentations at the Jefferies Global Healthcare Conference. The biopharmaceutical...

Ionis Pharmaceuticals is experiencing a dramatic upward trajectory, with its stock performance capturing significant market attention. The biotech firm's impressive...

Absci finds itself navigating turbulent financial waters as the biotechnology firm grapples with plunging revenue alongside aggressive investment in its...

Investors in Akero Therapeutics are bracing for a pivotal moment as the biopharmaceutical company approaches a decisive regulatory deadline. With...

While numerous biotechnology firms are scaling back expectations, Supernus Pharmaceuticals is projecting a surprisingly confident stance by reaffirming its annual...

Biotechnology firm Equillium is executing a profound strategic overhaul, pivoting its entire operational focus to a single, promising drug candidate....